Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author="Schnitzler, F" or (type any "bookEditor journalEditor issueEditor" and editor="Schnitzler...

Add to list
- Journal Article
- A1
Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti-TNF alpha antibodies

F Beigel, A Steinborn, F Schnitzler, C Tillack, S Breiteneicher, JM John, Kristel Van Steen (UGent) , RP Laubender, B Goke, J Seiderer, et al.

(2014) PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 23(7). p.735-744
Add to list
- Conference Paper
- C3
Rate of malignancies and infections in a large single center cohort of IBD patients treated with thiopurines and anti-TNF-antibodies

T Ochsenkuhn, A Steinbom, F Beigel, S Breiteneicher, Kristel Van Steen (UGent) , F Schnitzler, B Goke, M Weidinger, S Brand and L Seiderer

(2011) GASTROENTEROLOGY. 140(5, suppl. 1). p.S773-S773
Add to list
- Journal Article
- A1
Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy

F Schnitzler, H Fidder, M Ferrante, V Ballet, M Noman, G Van Assche, B Spitz, I Hoffman, Kristel Van Steen (UGent) , S Vermeire, et al.

(2011) INFLAMMATORY BOWEL DISEASES. 17(9). p.1846-1854
Add to list
- Journal Article
- A1
Levels of C-reactive protein are associated with response to infliximab therapy in patients with Crohn's disease

M Jurgens, JMM John, I Cleynen, F Schnitzler, H Fidder, W Van Moerkercke, V Ballet, M Noman, I Hoffman, G Van Assche, et al.

(2011) CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 9(5). p.421-U1420
Add to list
- Journal Article
- A1
Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease

F Schnitzler, H Fidder, M Ferrante, M Noman, I Arijs, G Van Assche, I Hoffman, Kristel Van Steen (UGent) , S Vermeire and P Rutgeerts

(2009) INFLAMMATORY BOWEL DISEASES. 15(9). p.1295-1301
Add to list
- Conference Paper
- C3
Predictive value of C-reactive protein level changes on the long term outcome of infliximab in Crohn's disease

M Jurgens, F Schnitzler, Kristel Van Steen (UGent) , J Mahachie, V Ballet, M Noman, I Hoffman, GA Van Assche, PJ Rutgeerts and S Venneire

(2009) GASTROENTEROLOGY. 136(5, suppl. 1). p.A171-A171
Add to list
- Journal Article
- A1
Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease : results from a single-centre cohort

F Schnitzler, H Fidder, M Ferrante, M Noman, I Arijs, G Van Assche, I Hoffman, Kristel Van Steen (UGent) , S Vermeire and P Rutgeerts

(2009) GUT. 58(4). p.492-500
Add to list
- Journal Article
- A1
Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis

I Arijs, K Li, G Toedter, R Quintens, L Van Lommel, Kristel Van Steen (UGent) , P Leemans, G De Hertogh, K Lemaire, M Ferrante, et al.

(2009) GUT. 58(12). p.1612-1619

Academic Bibliography

Risk of malignancies in patients with inflammatory bowel disease treated with thiopurines or anti-TNF alpha antibodies

Rate of malignancies and infections in a large single center cohort of IBD patients treated with thiopurines and anti-TNF-antibodies

Outcome of pregnancy in women with inflammatory bowel disease treated with antitumor necrosis factor therapy

Levels of C-reactive protein are associated with response to infliximab therapy in patients with Crohn's disease

Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease

Predictive value of C-reactive protein level changes on the long term outcome of infliximab in Crohn's disease

Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease : results from a single-centre cohort

Mucosal gene signatures to predict response to infliximab in patients with ulcerative colitis

Contents

Support

Contact